The oil industry continues its diversification work, investing more and more in renewable energies. Total Solar, a 100% owned Total subsidiary dedicated to solar activities, has launched construction of its second solar power plant in Japan. The 25-megawatt-peak photovoltaic power

Dong Energy will divest its upstream oil and gas business as part of the company’s green transformation and will change its organisational structure to expand the company’s position as a global leader in the transition to more sustainable energy systems. The

French industrial biotech company Global Bioenergies aims at demonstrating a new value chain combining its isobutene process with technologies developed by Clariant and INEOS, two of Europe’s leading chemical companies. The aim is to convert currently poorly valorised residual wheat

The bioeconomy speaks Japanese. Toshiba Corporation, a multinational conglomerate headquartered in Tokyo, started commercial operation of its first ever biomass power plant, a 50MW facility that will supply enough electricity for 80,000 households and reduce CO2 emissions to about 300,000

Dong Energy is a Danish focused energy company with a strong profile in renewables. Three of its power stations have said goodbye to coal and gas, and the next in line is now well on the way. Skærbæk Power Station

German multinational company Boehringer Ingelheim Animal Health and Danish biotech giant Novozymes entered into a strategic collaboration to develop and commercialize probiotics for global poultry production. The parties will focus on developing products for hatcheries, the facilities where eggs are

Switzerland-based Clariant, a world leader in specialty chemicals, breaks new ground for the indoor paint and coatings segment with the launch of the industry's first renewable-based, VOC/SVOC-free (volatile organic compounds and semivolatile organic compounds) and hazard label-free neutralizing agent: Genamin

Roquette, a global leader in innovative plant-based pharmaceutical ingredients, aims at providing new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. The French chemical colossus operates in over 100 countries, has a